Funded Tech Companies

NLS Pharmaceutics

Looking for the VC firms that provided funding to NLS Pharmaceutics? Private investors put venture money into this innovative biopharmaceutical company.

Company Overview

Company Name
NLS Pharmaceutics
Company Status
Private & Independent
Funding Rounds
Total Funding

Contact Information

Mailing Address
The Circle 6 | P.O. Box
Zurich, CH - 8058
Switzerland
Email Address

Company Background Information

Overview
Our Vision: Awaken a brighter future for patients by overcoming rare and complex CNS diseases. Our Mission: To Develop Better Therapies to Safeguard and Empower the Brain throughout all Stages of Life. NLS was formed in June 2015 in Stans, Switzerland, and is a Swiss limited company. In 2016, we acquired several patents from Assistance Publique -- Hopitaux de Paris, or AP-HP in France, including intellectual property for our lead compound, mazindol.
Profile
NLS Pharmaceutics LinkedIn Company Profile
Social Media
NLS Pharmaceutics Company Twitter Account
Company News
NLS Pharmaceutics News
Facebook
NLS Pharmaceutics on Facebook
YouTube
NLS Pharmaceutics on YouTube
Last Transaction
6/30/2025

Financing History

Date
Type
Amount
Venture Equity
$1,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Alex Zwyer
  Alex Zwyer LinkedIn Profile  Alex Zwyer Twitter Account  Alex Zwyer News  Alex Zwyer on Facebook


Company Investors

     

     

     

    Browse more funded tech companies:

    NLM Photonics | NLX

     

    Share this article

     


    About Our Venture Capital Database

    This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

     


    Additional Resources for Entrepreneurs

    Lists of Venture Capital and Private Equity Firms

    Franchise Opportunities

    Contributors

    Business Glossary